VAM
BMY icon

Vanguard Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Vanguard Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249M Buy
+4,101,345
New +$239M 0.21% 80

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Asset Management's BMY Position: Q1 2026 in Review

Vanguard Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 4,101,345 shares worth $249M. The stake represents 0.21% of the portfolio and ranks #80 among its holdings.

2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Vanguard Asset Management held 4,101,345 shares of Bristol-Myers Squibb worth $249M as of Q1 2026.
  • Bristol-Myers Squibb was a new Vanguard Asset Management position in Q1 2026.
  • Bristol-Myers Squibb made up 0.21% of Vanguard Asset Management's portfolio in Q1 2026, its #80 holding.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Vanguard Asset Management's 13F filing for Q1 2026, filed 8 May 2026.